ST. LOUIS, Oct. 18 /PRNewswire/ -- Monsanto Company, a subsidiary of
Pharmacia Corporation (NYSE: PHA), today announced that its initial public
offering of 35 million shares of common stock was priced at $20 per share.
All of the shares, which will be traded on the New York Stock Exchange under
the ticker symbol MON, were offered by Monsanto.
Goldman, Sachs & Co. is acting as the book running lead manager for the
offering. Salomon Smith Barney is acting as the joint lead manager. J.P.
Morgan & Co., Morgan Stanley Dean Witter, Bear, Stearns & Co. Inc., and
Merrill Lynch & Co. are co-managers for the offering. Monsanto has granted
the underwriters a 30-day option to purchase up to an additional 5,250,000
shares of common stock to cover over-allotments, if any. Copies of the final
prospectus relating to the offer may be obtained from Goldman, Sachs & Co. at
85 Broad Street, New York, NY 10004, 212-902-1000.
Monsanto Company provides integrated, technology-based agricultural
solutions for growers and downstream customers in agricultural markets. The
company's corporate headquarters are located in St. Louis. Following
completion of the offering, Pharmacia Corporation will continue to own more
than 84 percent of Monsanto's common stock.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of these
securities in any state in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of
any such state.
SOURCE Monsanto Company